Virios Therapeutics Inc
General ticker "VIRI" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $80.2M
Virios Therapeutics Inc does not follow the US Stock Market performance with the rate: -42.2%.
Estimated limits based on current volatility of 3.6%: low 4.22$, high 4.54$
Factors to consider:
- Earnings expected soon, date: 2024-11-11
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [4.82$, 20.52$]
- 2024-12-30 to 2025-12-30 estimated range: [2.99$, 12.96$]
Financial Metrics affecting the VIRI estimates:
- Negative: Non-GAAP EPS, $ of -0.28 <= 0.12
- Negative: Operating profit margin, % of -100 <= 1.51
- Negative: Operating cash flow per share per price, % of -1.62 <= 2.52
- Negative: Return on assets ratio (scaled to [-100,100]) of -55.97 <= 0
- Negative: Industry operating cash flow per share per price (median), % of -24.49 <= 3.96
Short-term VIRI quotes
Long-term VIRI plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $15.64MM | $12.32MM | $5.45MM |
| Operating Income | $-15.64MM | $-12.32MM | $-5.45MM |
| Non-Operating Income | $-0.32MM | $0.07MM | $0.15MM |
| Interest Expense | $0.01MM | $0.00MM | $0.00MM |
| R&D Expense | $10.80MM | $8.07MM | $1.73MM |
| Income(Loss) | $-15.96MM | $-12.25MM | $-5.30MM |
| Profit(Loss) | $-15.96MM | $-12.25MM | $-5.30MM |
| Stockholders Equity | $14.50MM | $7.33MM | $3.81MM |
| Assets | $15.78MM | $8.37MM | $4.17MM |
| Operating Cash Flow | $-15.69MM | $-11.47MM | $-4.87MM |
| Financing Cash Flow | $-0.10MM | $4.49MM | $1.16MM |
| Earnings Per Share* | $-1.92 | $-1.10 | $-0.28 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.